NEW YORK / RankWire.AI / – U.S. stocks closed with modest gains on Wednesday as yields on long-term Treasury bonds dropped sharply. The S&P 500 increased by 16.22 points, or 0.21%, ending at 7,707.98, breaking a three-day losing streak. The Dow Jones Industrial Average climbed 119.65 points, or 0.22%, to finish at 53,463.05. Meanwhile, the Nasdaq Composite gained 41.38 points, or 0.16%, closing at 26,331.09. The decline in government bond yields supported the major indices’ recovery after several sessions pressured by rising borrowing costs.
Bond prices moved upward following the U.S. Treasury Department’s announcement of increased liquidity support buybacks for longer-dated government debt. Beginning September 9, the maximum purchase amount will rise from $2 billion to at least $4 billion per operation. This change pertains to nominal coupon securities within the 10-to-20-year and 20-to-30-year maturity segments. These higher amounts will stay in effect through November 4. The department explained that high-quality offer volumes supported the decision to expand liquidity operations in those segments.
Following the announcement, Treasury yields declined, reversing some of the recent upward movement in long-term borrowing costs. The 10-year Treasury yield fell to approximately 4.65%, while the 30-year yield dropped to around 5.20%. On Tuesday, the 30-year yield reached 5.337%, its highest since 2007. Since bond yields move inversely to prices, increased demand for government debt caused yields to fall. This retreat alleviated some of the pressure that accompanied the recent selloff in longer-term government bonds.
Healthcare Sector Boosts Market Sentiment
Support for healthcare stocks contributed to Wednesday’s gains, with several pharmaceutical companies posting significant increases. Moderna shares soared by 177%, and Merck advanced by 12.6% after announcing positive results from a Phase 3 melanoma trial. The INTerpath-001 study evaluated personalized mRNA therapy intismeran autogene combined with Keytruda following surgical removal of high-risk melanoma. The trial met its primary endpoint of recurrence-free survival and also achieved a key secondary endpoint measuring survival without distant metastasis.
This rally in healthcare stocks helped counterbalance mixed trading elsewhere, particularly within the technology sector. Consumer-related equities also contributed, as several major firms released quarterly earnings during the session. Estée Lauder increased by over 16% following its earnings report, further boosting consumer stocks. Target and Lowe’s also saw gains after reporting their latest financial results. Smaller companies generally outperformed larger caps, with the Russell 2000 gaining roughly 0.5% as the broader market rebounded.
Major Benchmarks End Three-Day Losing Streak
The rally on Wednesday marked the end of three consecutive decline days for the S&P 500, Dow, and Nasdaq. The rebound followed earlier-week declines driven by higher long-term yields. Nonetheless, even after Wednesday’s increase, the key indexes remained lower for the week through the close. The S&P 500 was approximately 1% below last Friday’s level. The Dow had fallen about 0.5% for the week, while the Nasdaq was down around 1.5%.
Despite the weekly dip and recent bond market pressures, the year-to-date performance remained positive. As of Wednesday’s close, the S&P 500 had gained about 12.6% since the start of the year. The Dow had increased roughly 11.2%, and the Nasdaq outperformed with an approximately 13.3% rise, reflecting its stronger early-year momentum. Wednesday’s session thus represented a modest recovery for Wall Street, driven by lower Treasury yields and gains in the healthcare sector, lifting all three major U.S. stock indexes.